BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17287359)

  • 1. Lifelong accumulation of bone in mice lacking Pten in osteoblasts.
    Liu X; Bruxvoort KJ; Zylstra CR; Liu J; Cichowski R; Faugere MC; Bouxsein ML; Wan C; Williams BO; Clemens TL
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2259-64. PubMed ID: 17287359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth.
    Ford-Hutchinson AF; Ali Z; Lines SE; Hallgrímsson B; Boyd SK; Jirik FR
    J Bone Miner Res; 2007 Aug; 22(8):1245-59. PubMed ID: 17456009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively expressed COX-2 in osteoblasts positively regulates Akt signal transduction via suppression of PTEN activity.
    Li CJ; Chang JK; Wang GJ; Ho ML
    Bone; 2011 Feb; 48(2):286-97. PubMed ID: 20854947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells.
    Nielsen-Preiss SM; Silva SR; Gillette JM
    J Cell Biochem; 2003 Dec; 90(5):964-75. PubMed ID: 14624456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl2 deficiency activates FoxO through Akt inactivation and accelerates osteoblast differentiation.
    Moriishi T; Kawai Y; Komori H; Rokutanda S; Eguchi Y; Tsujimoto Y; Asahina I; Komori T
    PLoS One; 2014; 9(1):e86629. PubMed ID: 24466179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 promotes osteoblast proliferation and differentiation and protects against ovariectomy-induced osteoporosis.
    Zheng D; Cui C; Yu M; Li X; Wang L; Chen X; Lin Y
    Mol Med Rep; 2018 Jan; 17(1):400-407. PubMed ID: 29115467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies.
    Porzia A; Lanzardo S; Citti A; Cavallo F; Forni G; Santoni A; Galandrini R; Paolini R
    J Immunol; 2010 Apr; 184(8):4170-7. PubMed ID: 20220087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cadherin adherens junctions mediate osteogenesis through PI3K signaling.
    Guntur AR; Rosen CJ; Naski MC
    Bone; 2012 Jan; 50(1):54-62. PubMed ID: 21964322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The skeleton: a multi-functional complex organ: new insights into osteoblasts and their role in bone formation: the central role of PI3Kinase.
    Guntur AR; Rosen CJ
    J Endocrinol; 2011 Nov; 211(2):123-30. PubMed ID: 21673026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways.
    Raucci A; Bellosta P; Grassi R; Basilico C; Mansukhani A
    J Cell Physiol; 2008 May; 215(2):442-51. PubMed ID: 17960591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional ablation of Pten in osteoprogenitors stimulates FGF signaling.
    Guntur AR; Reinhold MI; Cuellar J; Naski MC
    Development; 2011 Apr; 138(7):1433-44. PubMed ID: 21385768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchyme-specific overexpression of nucleolar protein 66 in mice inhibits skeletal growth and bone formation.
    Chen Q; Zhang L; de Crombrugghe B; Krahe R
    FASEB J; 2015 Jun; 29(6):2555-65. PubMed ID: 25746793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling.
    Dufour C; Holy X; Marie PJ
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E794-801. PubMed ID: 18378961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
    Marsh J; Mukherjee P; Seyfried TN
    Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells.
    Kang-Park S; Im JH; Lee JH; Lee YI
    Virus Res; 2006 Dec; 122(1-2):53-60. PubMed ID: 16872708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.
    Hernando E; Charytonowicz E; Dudas ME; Menendez S; Matushansky I; Mills J; Socci ND; Behrendt N; Ma L; Maki RG; Pandolfi PP; Cordon-Cardo C
    Nat Med; 2007 Jun; 13(6):748-53. PubMed ID: 17496901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.